SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-005050
Filing Date
2022-04-04
Accepted
2022-04-04 16:08:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220404xdefa14a.htm DEFA14A 21001
2 GRAPHIC tmb-20220404xdefa14a002.jpg GRAPHIC 68094
3 GRAPHIC tmb-20220404xdefa14a001.jpg GRAPHIC 119593
  Complete submission text file 0001558370-22-005050.txt   280872
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 22802185
SIC: 2836 Biological Products, (No Diagnostic Substances)